Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REYATAZ vs RIFAMPIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REYATAZ vs RIFAMPIN: Safety Overview

Metric REYATAZ RIFAMPIN
Total FAERS Reports 142 13,347
Deaths Reported 12 1,439
Death Rate 8.5% 10.8%
Hospitalizations 50 5,764
Average Patient Age 44.8 yrs 51.7 yrs
% Female Patients N/A 47.8%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Hikma Pharmaceuticals USA Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Discontinued